ArticleRSC advances2026

Evaluation of 6-substituted coumarins as SARS-CoV-2 main protease inhibitors: enzymatic, cellular, and computational insights.

Ashraf K El-Damasy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.